Schonfeld Strategic Advisors LLC Delcath Systems, Inc. Transaction History

Schonfeld Strategic Advisors LLC

  • $13.8 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 14, 2022
SELL
$7.2 - $11.72 $587,520 - $956,352
-81,600 Closed
0 $0
Q3 2021

Nov 16, 2021
SELL
$8.44 - $12.65 $43,888 - $65,780
-5,200 Reduced 5.99%
81,600 $851,000
Q2 2021

Aug 16, 2021
SELL
$9.54 - $15.1 $214,029 - $338,768
-22,435 Reduced 20.54%
86,800 $1.1 Million
Q1 2021

May 17, 2021
BUY
$12.42 - $23.81 $1.36 Million - $2.6 Million
109,235 New
109,235 $1.36 Million

Others Institutions Holding DCTH

# of Institutions
73
Shares Held
7.62M
Call Options Held
198K
Put Options Held
41.7K
View Full List

About DELCATH SYSTEMS, INC.

DCTH Quotes by TradingView
  • Ticker DCTH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 8,597,680
  • Market Cap $83.3M
  • Description
  • Delcath Systems, Inc., an interventional oncology company, focuses on the treatment of primary and metastatic liver cancers in the United States and Europe. The company's lead product candidate is HEPZATO KIT, a melphalan hydrochloride for injection/hepatic delivery system to administer high-dose chemotherapy to the liver while controlling syste...
More about DCTH
Track This Portfolio

Track Schonfeld Strategic Advisors LLC Portfolio

Follow Schonfeld Strategic Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Schonfeld Strategic Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Schonfeld Strategic Advisors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email